AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
COMPARISON OF THE FREQUENCY AND DIFFERENTIATION ACTIVITY OF LYMPHO-MYELOID STEM-CELLS FROM HUMAN FETAL LIVER, CORD-BLOOD AND ADULT MARROW USING AN IMPROVED NOD SCID REPOPULATION ASSAY/
Authors: HOLYOAKE TL NICOLINI FE EAVES CJ
Citation: Tl. Holyoake et al., COMPARISON OF THE FREQUENCY AND DIFFERENTIATION ACTIVITY OF LYMPHO-MYELOID STEM-CELLS FROM HUMAN FETAL LIVER, CORD-BLOOD AND ADULT MARROW USING AN IMPROVED NOD SCID REPOPULATION ASSAY/, Experimental hematology, 26(8), 1998, pp. 241-241
DEVELOPMENT OF IMMUNOMAGNETIC NEGATIVE DEPLETION PROCEDURES FOR OBTAINING ENRICHED POPULATIONS OF PRIMITIVE CELLS FROM CML BLOOD-SAMPLES ORTHEIR PROGENY REGENERATED IN NOD SCID MICE/
Authors: HOLYOAKE TL CAMERON G HORROCKS C THOMAS T EAVES C EAVES A
Citation: Tl. Holyoake et al., DEVELOPMENT OF IMMUNOMAGNETIC NEGATIVE DEPLETION PROCEDURES FOR OBTAINING ENRICHED POPULATIONS OF PRIMITIVE CELLS FROM CML BLOOD-SAMPLES ORTHEIR PROGENY REGENERATED IN NOD SCID MICE/, Experimental hematology, 26(8), 1998, pp. 266-266
IDENTIFICATION AND CHARACTERIZATION OF PRIMITIVE, QUIESCENT, PH+ CELLS IN CML PATIENTS
Authors: HOLYOAKE TL JIANG X EAVES C EAVES A
Citation: Tl. Holyoake et al., IDENTIFICATION AND CHARACTERIZATION OF PRIMITIVE, QUIESCENT, PH+ CELLS IN CML PATIENTS, Experimental hematology, 26(8), 1998, pp. 267-267
TELOMERE LENGTH IN NORMAL AND MALIGNANT-CELLS FROM PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA MEASURED BY FLOW-CYTOMETRY
Authors: BRUMMENDORF TH HOLYOAKE TL RULER N DRAGOWSKA W CHAVEZ E BARNETT M MCCAUL K EAVES CJ EAVES AC LANSDORP PM
Citation: Th. Brummendorf et al., TELOMERE LENGTH IN NORMAL AND MALIGNANT-CELLS FROM PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA MEASURED BY FLOW-CYTOMETRY, Experimental hematology, 26(8), 1998, pp. 408-408
AUTOCRINE PRODUCTION AND ACTION OF IL-3 AND G-CSF ON PH+ CD34+ CELLS FROM PATIENTS WITH CML
Authors: JIANG X LOPEZ A HOLYOAKE TL EAVES A EAVES C
Citation: X. Jiang et al., AUTOCRINE PRODUCTION AND ACTION OF IL-3 AND G-CSF ON PH+ CD34+ CELLS FROM PATIENTS WITH CML, Experimental hematology, 26(8), 1998, pp. 436-436
THE ERYTHROPOIETIC POTENTIAL DISPLAYED BY PRIMITIVE HUMAN FETAL LIVER-CELLS IN-VITRO AND IN-VIVO IS GREATER-THAN THAT OF THEIR COUNTERPARTSIN CORD-BLOOD OR ADULT BONE-MARROW
Authors: NICOLINI FE HOLYOAKE TL LAMBIE K EAVES CJ
Citation: Fe. Nicolini et al., THE ERYTHROPOIETIC POTENTIAL DISPLAYED BY PRIMITIVE HUMAN FETAL LIVER-CELLS IN-VITRO AND IN-VIVO IS GREATER-THAN THAT OF THEIR COUNTERPARTSIN CORD-BLOOD OR ADULT BONE-MARROW, Experimental hematology, 26(8), 1998, pp. 459-459
CD34-BLOOD PROGENITOR CELLS AND CAN RETAIN THEIR PROLIFERATIVE POTENTIAL( CELLS CAN BE SELECTED EFFICIENTLY FROM CRYOPRESERVED PERIPHERAL)
Authors: ALCORN MJ HOLYOAKE TL RICHMOND LJ PEARSON C FARRELL E GREEN R DUNLOP DJ FRANKLIN IM
Citation: Mj. Alcorn et al., CD34-BLOOD PROGENITOR CELLS AND CAN RETAIN THEIR PROLIFERATIVE POTENTIAL( CELLS CAN BE SELECTED EFFICIENTLY FROM CRYOPRESERVED PERIPHERAL), Journal of hematotherapy, 6(5), 1997, pp. 501-510
CD34 POSITIVE PBPC EXPANDED EX-VIVO MAY NOT PROVIDE DURABLE ENGRAFTMENT FOLLOWING MYELOABLATIVE CHEMORADIOTHERAPY REGIMENS
Authors: HOLYOAKE TL ALCORN MJ RICHMOND L FARRELL E PEARSON C GREEN R DUNLOP DJ FITZSIMONS E PRAGNELL IB FRANKLIN IM
Citation: Tl. Holyoake et al., CD34 POSITIVE PBPC EXPANDED EX-VIVO MAY NOT PROVIDE DURABLE ENGRAFTMENT FOLLOWING MYELOABLATIVE CHEMORADIOTHERAPY REGIMENS, Bone marrow transplantation, 19(11), 1997, pp. 1095-1101
DEVELOPMENT AND VALIDATION OF AN IMPROVED IN-VIVO ASSAY FOR QUANTITATING HUMAN HEMATOPOIETIC STEM-CELLS
Authors: HOLYOAKE TL NICOLINI F CASHMAN J EAVES CJ
Citation: Tl. Holyoake et al., DEVELOPMENT AND VALIDATION OF AN IMPROVED IN-VIVO ASSAY FOR QUANTITATING HUMAN HEMATOPOIETIC STEM-CELLS, Blood, 90(10), 1997, pp. 697-697
EX-VIVO EXPANSION OF HEMATOPOIETIC PROGENITOR CELLS
Authors: ALCORN MJ HOLYOAKE TL
Citation: Mj. Alcorn et Tl. Holyoake, EX-VIVO EXPANSION OF HEMATOPOIETIC PROGENITOR CELLS, Blood reviews, 10(3), 1996, pp. 167-176
CYTOKINES AT THE RESEARCH-CLINICAL INTERFACE - POTENTIAL APPLICATIONS
Authors: HOLYOAKE TL
Citation: Tl. Holyoake, CYTOKINES AT THE RESEARCH-CLINICAL INTERFACE - POTENTIAL APPLICATIONS, Blood reviews, 10(3), 1996, pp. 189-200
ENGRAFTMENT OF PROGENITOR CELLS GENERATED EX-VIVO MAY NOT PROVE DURABLE AFTER MYELOABLATIVE CONDITIONING
Authors: HOLYOAKE TL ALCORN MA RICHMOND L FARRELL E PEARSON C GREEN R FITSZIMONS E DUNLOP DJ PRAGNELL IB FRANKLIN IM
Citation: Tl. Holyoake et al., ENGRAFTMENT OF PROGENITOR CELLS GENERATED EX-VIVO MAY NOT PROVE DURABLE AFTER MYELOABLATIVE CONDITIONING, British Journal of Haematology, 93, 1996, pp. 45-45
IMPROVED EX-VIVO EXPANSION OF CD34 SELECTED PBPC USING HIGH EXPANSIONCULTURE BAGS
Authors: ALCORN MJ HOLYOAKE TL RICHMOND LJ PEARSON C FARRELL E GREEN R DUNLOP DJ FITZSIMONS E FRANKLIN IM
Citation: Mj. Alcorn et al., IMPROVED EX-VIVO EXPANSION OF CD34 SELECTED PBPC USING HIGH EXPANSIONCULTURE BAGS, British Journal of Haematology, 93, 1996, pp. 159-159
CD34 POSITIVE CELLS CAN BE SELECTED EFFICIENTLY FROM CRYOPRESERVED PBPC
Authors: ALCORN MJ HOLYOAKE TL RICHMOND LJ PEARSON C FARRELL E GREEN R DUNLOP DJ FRANKLIN IM
Citation: Mj. Alcorn et al., CD34 POSITIVE CELLS CAN BE SELECTED EFFICIENTLY FROM CRYOPRESERVED PBPC, British Journal of Haematology, 93, 1996, pp. 160-160
AN EVALUATION OF THE FEASIBILITY OF USING CD34 POSITIVE CELLS EXPANDED EX-VIVO FOR TRANSPLANTATION
Authors: HOLYOAKE TL ALCORN MJ RICHMOND L PEARSON C FARRELL E KYLE B DUNLOP DJ FITZSIMONS E STEWARD WP PRAGNELL IB FRANKLIN IM
Citation: Tl. Holyoake et al., AN EVALUATION OF THE FEASIBILITY OF USING CD34 POSITIVE CELLS EXPANDED EX-VIVO FOR TRANSPLANTATION, British Journal of Haematology, 93, 1996, pp. 162-162
EX-VIVO EXPANSION WITH STEM-CELL FACTOR AND INTERLEUKIN-11 AUGMENTS BOTH SHORT-TERM RECOVERY POSTTRANSPLANT AND THE ABILITY TO SERIALLY TRANSPLANT MARROW
Authors: HOLYOAKE TL FRESHNEY MG MCNAIR L PARKER AN MCKAY PJ STEWARD WP FITZSIMONS E GRAHAM GJ PRAGNELL IB
Citation: Tl. Holyoake et al., EX-VIVO EXPANSION WITH STEM-CELL FACTOR AND INTERLEUKIN-11 AUGMENTS BOTH SHORT-TERM RECOVERY POSTTRANSPLANT AND THE ABILITY TO SERIALLY TRANSPLANT MARROW, Blood, 87(11), 1996, pp. 4589-4595
A FEASIBILITY STUDY OF EX-VIVO EXPANSION OF CD34 POSITIVE PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) ON A CLINICAL-SCALE
Authors: HOLYOAKE TL ALCORN MJ RICHMOND L PEARSON C FARRELL E KYLE B DUNLOP DJ FITZSIMONS E PRAGNELL IB FRANKLIN IM
Citation: Tl. Holyoake et al., A FEASIBILITY STUDY OF EX-VIVO EXPANSION OF CD34 POSITIVE PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) ON A CLINICAL-SCALE, Experimental hematology, 23(8), 1995, pp. 760-760
MAINTENANCE OF LONG-TERM RECONSTITUTING CELLS (LTRC) DURING EX-VIVO EXPANSION - EFFECT OF MIP-1-ALPHA
Authors: HOLYOAKE TL MCNAIR L FRESHNEY MG PARKER AN PRAGNELL IB
Citation: Tl. Holyoake et al., MAINTENANCE OF LONG-TERM RECONSTITUTING CELLS (LTRC) DURING EX-VIVO EXPANSION - EFFECT OF MIP-1-ALPHA, Experimental hematology, 23(8), 1995, pp. 846-846
EXPANSION OF CD34-BLOOD PROGENITOR CELLS (PBPC)( CELLS ISOLATED FROM CRYOPRESERVED MOBILIZED PERIPHERAL)
Authors: ALCORN MJ HOLYOAKE TL RICHMOND LJ PEARSON C FARRELL E KYLE B DUNLOP D FITZSIMONS EJ PRAGNELL IB FRANKLIN IM
Citation: Mj. Alcorn et al., EXPANSION OF CD34-BLOOD PROGENITOR CELLS (PBPC)( CELLS ISOLATED FROM CRYOPRESERVED MOBILIZED PERIPHERAL), Experimental hematology, 23(8), 1995, pp. 909-909
CD34 SELECTION USING THE BAXTER-ISOLEX-300 SYSTEM - COMPARISON BETWEEN FRESH PBPC AND CRYOPRESERVED PBPC
Authors: ALCORN MJ HOLYOAKE TL RICHMOND LJ PEARSON C FARRELL E KYLE B DUNLOP DJ FITZSIMONS E STEWARD WP PRAGNELL IB FRANKLIN IM
Citation: Mj. Alcorn et al., CD34 SELECTION USING THE BAXTER-ISOLEX-300 SYSTEM - COMPARISON BETWEEN FRESH PBPC AND CRYOPRESERVED PBPC, Blood, 86(10), 1995, pp. 907-907
A PHASE-I STUDY TO EVALUATE THE SAFETY OF RE-INFUSING CD34 CELLS EXPANDED EX-VIVO AS PART OR ALL OF A PBPC TRANSPLANT PROCEDURE
Authors: HOLYOAKE TL ALCORN MJ RICHMOND L PEARSON C FARRELL E KYLE B DUNLOP DJ FITZSIMONS E STEWARD WP PRAGNELL IB FRANKLIN JM
Citation: Tl. Holyoake et al., A PHASE-I STUDY TO EVALUATE THE SAFETY OF RE-INFUSING CD34 CELLS EXPANDED EX-VIVO AS PART OR ALL OF A PBPC TRANSPLANT PROCEDURE, Blood, 86(10), 1995, pp. 1161-1161
EFFICIENT ISOLATION OF HUMAN CD34 POSITIVE HEMATOPOIETIC PROGENITOR CELLS BY IMMUNE PANNING (VOL 12, PG 114-124, 1994)
Authors: HOLYOAKE TL ALCORN MJ RICHMOND LJ FRESHNEY MG PEARSON C FITZSIMONS E STEWARD WP DUNLOP DJ PRAGNELL IB
Citation: Tl. Holyoake et al., EFFICIENT ISOLATION OF HUMAN CD34 POSITIVE HEMATOPOIETIC PROGENITOR CELLS BY IMMUNE PANNING (VOL 12, PG 114-124, 1994), Stem cells, 12(2), 1994, pp. 233-233
EFFICIENT ISOLATION OF HUMAN CD34 POSITIVE HEMATOPOIETIC PROGENITOR CELLS BY IMMUNE PANNING
Authors: HOLYOAKE TL ALCORN MJ RICHMOND LJ FRESHNEY MG PEARSON C FITZSIMONS E STEWARD WP DUNLOP DJ PRAGNELL IB
Citation: Tl. Holyoake et al., EFFICIENT ISOLATION OF HUMAN CD34 POSITIVE HEMATOPOIETIC PROGENITOR CELLS BY IMMUNE PANNING, Stem cells, 12(1), 1994, pp. 114-124
BONE-MARROW TRANSPLANTS FROM PERIPHERAL-BLOOD
Authors: HOLYOAKE TL FRANKLIN IM
Citation: Tl. Holyoake et Im. Franklin, BONE-MARROW TRANSPLANTS FROM PERIPHERAL-BLOOD, BMJ. British medical journal, 309(6946), 1994, pp. 4-5
CONTRASTING EFFECTS OF INTERLEUKIN-3 (IL-3) DURING EX-VIVO EXPANSION OF MURINE BONE-MARROW PROGENITORS IN SERUM CONTAINING VERSUS SERUM-FREE MEDIA
Authors: HOLYOAKE TL WILKIE AM FRESHNEY MG PRAGNELL IB
Citation: Tl. Holyoake et al., CONTRASTING EFFECTS OF INTERLEUKIN-3 (IL-3) DURING EX-VIVO EXPANSION OF MURINE BONE-MARROW PROGENITORS IN SERUM CONTAINING VERSUS SERUM-FREE MEDIA, Experimental hematology, 22(8), 1994, pp. 742-742
Risultati: 1-25 | 26-31